Haleon plc (NYSE:HLN) Given Average Rating of “Moderate Buy” by Brokerages

Haleon plc (NYSE:HLN) has received an average recommendation of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $10.95.

A number of research analysts recently commented on the stock. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. HSBC reiterated a “hold” rating on shares of Haleon in a research note on Wednesday. Hsbc Global Res lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Finally, Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th.

Institutional Trading of Haleon

A number of institutional investors have recently bought and sold shares of the business. Brucke Financial Inc. bought a new stake in Haleon in the 4th quarter valued at about $96,000. Forum Financial Management LP boosted its holdings in Haleon by 52.2% in the 4th quarter. Forum Financial Management LP now owns 30,705 shares of the company’s stock valued at $293,000 after purchasing an additional 10,530 shares during the period. Vise Technologies Inc. lifted its holdings in shares of Haleon by 21.5% during the 4th quarter. Vise Technologies Inc. now owns 59,125 shares of the company’s stock worth $564,000 after acquiring an additional 10,468 shares during the period. Principal Street Partners LLC bought a new stake in shares of Haleon during the 4th quarter worth approximately $472,000. Finally, Wolverine Trading LLC bought a new stake in shares of Haleon during the 4th quarter worth approximately $208,000. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Up 0.5 %

Haleon stock opened at $10.45 on Friday. Haleon has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The firm has a market capitalization of $47.29 billion, a PE ratio of 30.72, a P/E/G ratio of 2.82 and a beta of 0.25. The company’s 50-day moving average is $9.68 and its 200-day moving average is $9.86. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58.

Haleon (NYSE:HLN) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Sell-side analysts anticipate that Haleon will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The firm also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be issued a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. This is an increase from Haleon’s previous — dividend of $0.05. Haleon’s payout ratio is currently 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.